Xlife Sciences : From academic innovation to industrial value creation
Xlife Sciences is a unique model in the European life sciences ecosystem, combining academic incubation, industrial structuring and the strategic monetisation of innovative assets. The transaction with Landsteiner and the prospect of a US listing represent a major strategic turning point for Xlife, increasing financial growth while giving substance to its business model. It values 12 of the group's projects at $ 450m, which is more than Xlife's current market capitalisation. In the short term, VERAXA's IPO on the NASDAQ will be a catalyst for the share price. We are initiating coverage of the stock with an Outperform rating and a target price of CHF 50 per share, offering discount of 20% on NAV.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.